Rights and permissions
About this article
Cite this article
Donepezil cost saving to society in moderate-to-severe AD. Pharmacoecon. Outcomes News 463, 7 (2004). https://doi.org/10.2165/00151234-200404630-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404630-00016